October 17, 2017
Via: ForbesEarly this month, I went to Washington, D.C., to serve as a witness for a hearing on “Examining Patient Access to Investigational Drugs” held by the Subcommittee on Health of the House of Representatives’ Committee on Energy and Commerce. The […]
March 28, 2024
April 19, 2024